Evidence map›Paper›PMID 37710249›Full record

ReviewCell communication and signaling : CCS2023

The roles of different microRNAs in the regulation of cholesterol in viral hepatitis.

Xuan Meng, Yeganeh Eslami, Ehsan Derafsh, Anwar Saihood, Nikoo Emtiazi, Saman Yasamineh, Omid Gholizadeh, Renzon Daniel Cosme Pecho

Erratum issuedOpen access · goldAbstract readVideo-Audio MediaReview
In one paragraph

Review in Cell communication and signaling : CCS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 5 countries.

Xuan MengHepatobiliary Surgery Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yeganeh EslamiFaculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Ehsan DerafshWindsor University, School of Medicine, St. Kitts, Canada.
Anwar SaihoodDepartment of Microbiology, college of medicine, University of Al-Qadisiyah, Baqubah, Iraq.
Nikoo EmtiaziDepartment of Pathology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Saman YasaminehYoung Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
Omid GholizadehDepartment of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. ogholizade1374@gmail.com.
Renzon Daniel Cosme PechoDepartment of Biochemistry, UNIVERSIDAD SAN IGNACIO DE LOYOLA (USIL), Lima, Peru.
Iran University of Medical Sciences · IRIslamic Azad University of Tabriz · IRMazandaran University of Medical Sciences · IRTabriz University of Medical Sciences · IRUniversidad San Ignacio de Loyola · PEUniversity of Al-Qadisiyah · IQUniversity of Windsor · CAXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholesterol plays a significant role in stabilizing lipid or membrane rafts, which are specific cellular membrane structures. Cholesterol is involved in numerous cellular processes, including regulating virus entry into the host cell. Multiple viruses have been shown to rely on cholesterol for virus entry and/or morphogenesis. Research indicates that reprogramming of the host's lipid metabolism is associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in the progression to severe liver disease for viruses that cause chronic hepatitis. Moreover, knowing the precise mode of viral interaction with target cells sheds light on viral pathogenesis and aids in the development of vaccines and therapeutic targets. As a result, the area of cholesterol-lowering therapy is quickly evolving and has many novel antiviral targets and medications. It has been shown that microRNAs (miRNAs) either directly or indirectly target the viral genome, preventing viral replication. Moreover, miRNAs have recently been shown to be strong post-transcriptional regulators of the genes involved in lipid metabolism, particularly those involved in cholesterol homeostasis. As important regulators of lipid homeostasis in several viral infections, miRNAs have recently come to light. In addition, multiple studies demonstrated that during viral infection, miRNAs modulate several enzymes in the mevalonate/cholesterol pathway. As cholesterol metabolism is essential to the life cycle of viral hepatitis and other viruses, a sophisticated understanding of miRNA regulation may contribute to the development of a novel anti-HCV treatment. The mechanisms underlying the effectiveness of miRNAs as cholesterol regulators against viral hepatitis are explored in this review. Video Abstract.

Indexed as

AntibodiesHepatitis, Viral, HumanCell MembraneCholesterolHepatitis B virusHumansAntibodiesCholesterolCholesterolmicroRNAsViral hepatitisViral infections

Identifiers

PMID37710249
PMCPMC10500852
OpenAlexW4386744497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.